Jan 12, 2023 / 07:15PM GMT
Matthew Alexander Bannon - JPMorgan Chase & Co, Research Division - Former Analyst
Hello, everyone. Welcome to JPMorgan Healthcare Conference. My name is Matt Bannon. I'm a health care banker here at JPM. I am really excited to be setting the stage for a next presenting company, Sutro Biopharma. And presenting on behalf of Sutro, we have CEO, Bill Newell.
William J. Newell - Sutro Biopharma, Inc. - CEO & Director
Thank you, Matt, and thank you to JPMorgan for giving us the opportunity to help you all close out the conference this year. I'm Bill Newell, I'm the CEO of Sutro Biopharma. And as you might imagine, in my discussions today with you, we're going to make some forward-looking statements and our legal team appreciates it, if you would pay attention to this slide because it indicates things that you need to know about those forward-looking statements.
When I first came to Sutro in 2009, I was the 19th employee. We had a novel proprietary cell-free protein synthesis platform, it was unique and it was a long way away from being where we are
Sutro Biopharma Inc at JPMorgan Healthcare Conference Transcript
Jan 13, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers